Journal of Biomedical Materials Research Part B, Applied Biomaterials · Nov 9, 2026

SilMA Hydrogel‐Delivered Human Amniotic Epithelial Stem Cells Promote Bone Regeneration Through COL8A1 ‐Mediated Osteogenesis and Angiogenesis With Coupled M2 Polarization

By Li M, Li C, Gao W

Critical‐sized bone defects remain a major clinical challenge. Human amniotic epithelial cells (hAECs) hold translational promise for bone regeneration, but the molecular effectors of their paracrine activity are poorly defined. Here, we used an injectable, photocrosslinkable silk fibroin methacryloyl (SilMA) hydrogel as a localized delivery vehicle for hAECs. Integrating bioinformatic mining of the publicly available GSE57265 RNA‐seq dataset with loss‐of‐function validation, we identified COL8A1 as a hub paracrine effector enriched in osteogenically primed hAECs. Transwell assays showed that hAEC secretions enhance hBMSC osteogenesis and HUVEC angiogenesis, and COL8A1 knockdown significantly attenuated both effects, establishing COL8A1 as functionally required for the hAEC secretome. The SilMA hydrogel sustained encapsulated hAEC viability, and systematic characterization of the three formulations identified 15% SilMA as offering the optimal balance between gelation kinetics, mechanical support, degradability and cytocompatibility. Subcutaneous implantation revealed that SilMA/hAECs composites shift macrophage polarization toward an anti‐inflammatory M2 phenotype. In a rat 5‐mm calvarial defect model, SilMA/hAECs enhanced bone regeneration at 4 and 8 weeks, with increased BV/TV, vascular density and osteoblast abundance. This study establishes SilMA‐delivered hAECs—acting through COL8A1 paracrine signaling—as a polymeric‐biomaterial strategy that concurrently engages osteogenic, angiogenic and immunomodulatory programs for bone repair.

doi.org/10.1002/jbm.b.70195PubMed 43001352Interventions

AgingResearch.News